Published in Virchows Arch A Pathol Anat Histopathol on January 01, 1987
Hedgehog signaling regulates epithelial-mesenchymal transition during biliary fibrosis in rodents and humans. J Clin Invest (2008) 2.89
Use of monoclonal antibodies to keratin 7 in the differential diagnosis of adenocarcinomas. Am J Pathol (1990) 1.65
Ber-EP4: new monoclonal antibody which distinguishes epithelia from mesothelial. J Clin Pathol (1990) 1.60
Transforming growth factors beta 1 and beta 2 are differentially expressed in fibrotic liver disease. Am J Pathol (1991) 1.55
Immunolocalization of putative human liver progenitor cells in livers from patients with end-stage primary biliary cirrhosis and sclerosing cholangitis using the monoclonal antibody OV-6. Am J Pathol (1998) 1.33
Neuroendocrine features of reactive bile ductules in cholestatic liver disease. Am J Pathol (1990) 1.28
Cell proliferation and oncogene expression after bile duct ligation in the rat: evidence of a specific growth effect on bile duct cells. Hepatology (1995) 1.27
Human intrahepatic biliary epithelial cells proliferate in vitro in response to human hepatocyte growth factor. J Clin Invest (1992) 1.12
Cell behavior in the acetylaminofluorene-treated regenerating rat liver. Light and electron microscopic observations. Am J Pathol (1994) 1.06
Distribution of albumin and alpha-fetoprotein mRNAs in normal, hyperplastic, and preneoplastic rat liver. Am J Pathol (1992) 1.00
The biology of cancer stem cells and its clinical implication in hepatocellular carcinoma. Gut Liver (2012) 0.93
Keratin 19 marks poor differentiation and a more aggressive behaviour in canine and human hepatocellular tumours. Comp Hepatol (2010) 0.92
Small epithelial cells and the histogenesis of hepatoblastoma. Electron microscopic, immunoelectron microscopic, and immunohistochemical findings. Am J Pathol (1996) 0.89
Characterization of biliary epithelial cells isolated from needle biopsies of human liver in the presence of hepatocyte growth factor. Am J Pathol (1995) 0.86
Canine liver transplantation model and the intermediate filaments of the cytoskeleton of the hepatocytes. J Biomed Biotechnol (2012) 0.78
Isolation and culture of biliary epithelial cells from bile duct remnants of patients with biliary atresia. Pediatr Surg Int (2004) 0.75
International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol (1999) 9.11
Safety and efficacy of imatinib (STI571) in metastatic gastrointestinal stromal tumours: a phase I study. Lancet (2001) 6.11
A classification of chronic hepatitis. Lancet (1968) 6.07
Consensus meeting for the management of gastrointestinal stromal tumors. Report of the GIST Consensus Conference of 20-21 March 2004, under the auspices of ESMO. Ann Oncol (2005) 5.27
Deletion of the hypoxia-response element in the vascular endothelial growth factor promoter causes motor neuron degeneration. Nat Genet (2001) 4.66
Malignant angiomyolipoma of the liver: a hitherto unreported variant. Histopathology (2000) 3.24
Cytogenetic evidence of clonality in cutaneous benign fibrous histiocytomas: a report of the CHAMP study group. Histopathology (2000) 3.05
The der(17)t(X;17)(p11;q25) of human alveolar soft part sarcoma fuses the TFE3 transcription factor gene to ASPL, a novel gene at 17q25. Oncogene (2001) 2.97
18FDG-Positron emission tomography for the early prediction of response in advanced soft tissue sarcoma treated with imatinib mesylate (Glivec). Eur J Cancer (2003) 2.97
Coordinated expression and amplification of the MDM2, CDK4, and HMGI-C genes in atypical lipomatous tumours. J Pathol (2000) 2.56
Correlation between clinicopathological features and karyotype in lipomatous tumors. A report of 178 cases from the Chromosomes and Morphology (CHAMP) Collaborative Study Group. Am J Pathol (1996) 2.42
Differential distribution of hepatitis B surface antigen and hepatitis B core antigen in the liver of hepatitis B patients. Gastroenterology (1976) 2.17
Prominent axonopathy in the brain and spinal cord of transgenic mice overexpressing four-repeat human tau protein. Am J Pathol (1999) 2.12
MRI findings in acute cerebellitis. Eur Radiol (2004) 2.12
Cytogenetic and fluorescence in situ hybridization investigation of ring chromosomes characterizing a specific pathologic subgroup of adipose tissue tumors. Cancer Genet Cytogenet (1993) 1.77
Resistance of young gelatinase B-deficient mice to experimental autoimmune encephalomyelitis and necrotizing tail lesions. J Clin Invest (1999) 1.64
Incomplete septal cirrhosis: histopathological aspects. Histopathology (1988) 1.63
Elevated risk for MPNST in NF1 microdeletion patients. Am J Hum Genet (2003) 1.62
Trisomies 8 and 20 in desmoid tumors. Cancer Genet Cytogenet (1996) 1.61
The development of the intrahepatic bile ducts in man: a keratin-immunohistochemical study. Hepatology (1988) 1.59
Arsenic and non-cirrhotic portal hypertension. A report of eight cases. J Hepatol (1990) 1.59
Plasmacytoid monocytes (so-called plasmacytoid T cells) in granulomatous lymphadenitis. Hum Pathol (1989) 1.51
Combined morphologic and karyotypic study of 59 atypical lipomatous tumors. Evaluation of their relationship and differential diagnosis with other adipose tissue tumors (a report of the CHAMP Study Group). Am J Surg Pathol (1996) 1.48
Plasmacytoid T cells. Immunohistochemical evidence for their monocyte/macrophage origin. Am J Pathol (1988) 1.46
Human and rat hepatic stellate cells express neurotrophins and neurotrophin receptors. Hepatology (2001) 1.46
Immunofluorescent detection of hepatitis B antigen in paraffin-embedded liver tissue. J Immunol Methods (1975) 1.44
Prominent cerebral amyloid angiopathy in transgenic mice overexpressing the london mutant of human APP in neurons. Am J Pathol (2000) 1.42
Complex tumor-specific t(X;18) in seven synovial sarcoma tumors. Cancer Genet Cytogenet (2009) 1.41
Distribution patterns of hepatitis B surface antigen (HBsAg) in the liver of hepatitis patients. J Clin Pathol (1976) 1.41
Immunohistochemical study of adhesion molecules in liver inflammation. Hepatology (1990) 1.40
PLAG1 fusion oncogenes in lipoblastoma. Cancer Res (2000) 1.35
Uneven hepatic iron and phosphorus distribution in beta-thalassemia. J Hepatol (1995) 1.33
Histochemistry of gamma-glutamyl transpeptidase in rat liver during aflatoxin B1-induced carcinogenesis. J Natl Cancer Inst (1975) 1.33
Administration of human fibroblast interferon in chronic hepatitis-B infection. Lancet (1976) 1.31
A phase II trial with rosiglitazone in liposarcoma patients. Br J Cancer (2003) 1.31
Synovial sarcoma of the larynx and hypopharynx. Ann Otol Rhinol Laryngol (1998) 1.31
Collagenous colitis: an abnormal collagen table? Two new cases and review of the literature. Am J Gastroenterol (1982) 1.30
Neuroendocrine features of reactive bile ductules in cholestatic liver disease. Am J Pathol (1990) 1.28
Intrahepatic bile duct development in the rat: a cytokeratin-immunohistochemical study. Lab Invest (1988) 1.27
In situ distribution of major histocompatibility complex products and viral antigens in chronic hepatitis B virus infection: evidence that HBc-containing hepatocytes may express HLA-DR antigens. Hepatology (1986) 1.24
Cytokeratin expression in hepatocellular carcinoma: an immunohistochemical study. Hum Pathol (1988) 1.23
A cytokeratin immunohistochemical study of cholestatic liver disease: evidence that hepatocytes can express 'bile duct-type' cytokeratins. Histopathology (1989) 1.23
Intrahepatic bile ducts under the lens. J Hepatol (1985) 1.22
Aneurysmal bone cyst of the nose with 17p13 involvement. Virchows Arch (2001) 1.21
Hepatic injury associated with the use of nitrofurans: a clinicopathological study of 52 reported cases. Hepatology (1988) 1.20
TuBaFrost 2: Standardising tissue collection and quality control procedures for a European virtual frozen tissue bank network. Eur J Cancer (2006) 1.20
Correlation between clinicopathological features and karyotype in spindle cell sarcomas. A report of 130 cases from the CHAMP study group. Am J Pathol (1999) 1.19
Cytogenetic characterization of peripheral nerve sheath tumours: a report of the CHAMP study group. J Pathol (2000) 1.18
MicroRNA-206 expression levels correlate with clinical behaviour of rhabdomyosarcomas. Br J Cancer (2010) 1.16
Expression of gelatinase B and the extracellular matrix metalloproteinase inducer EMMPRIN in benign and malignant pigment cell lesions of the skin. Am J Pathol (1997) 1.16
Dysfibrinogenaemia associated with primary hepatoma. Scand J Haematol (1972) 1.16
Extraorbital inflammatory pseudotumor of the head and neck: CT and MR findings in three patients. AJNR Am J Neuroradiol (1999) 1.16
Additional evidence of a variant translocation t(12;22) with EWS/CHOP fusion in myxoid liposarcoma: clinicopathological features. J Pathol (1997) 1.15
Hepatitis-B surface antigen in tumour tissue and non-tumorous liver in black patients with hepatocellular carcinoma. Br J Cancer (1980) 1.14
High frequency of beta-catenin heterozygous mutations in extra-abdominal fibromatosis: a potential molecular tool for disease management. Br J Cancer (2010) 1.14
Is calcifying fibrous pseudotumor a late sclerosing stage of inflammatory myofibroblastic tumor? Am J Surg Pathol (1999) 1.14
Cytogenetic analysis of 46 pleomorphic soft tissue sarcomas and correlation with morphologic and clinical features: a report of the CHAMP Study Group. Chromosomes and MorPhology. Genes Chromosomes Cancer (1998) 1.14
The NPM-ALK and the ATIC-ALK fusion genes can be detected in non-neoplastic cells. Am J Pathol (2001) 1.13
MGMT promoter hypermethylation correlates with a survival benefit from temozolomide in patients with recurrent anaplastic astrocytoma but not glioblastoma. Eur J Cancer (2008) 1.12
Prominent axonopathy and disruption of axonal transport in transgenic mice expressing human apolipoprotein E4 in neurons of brain and spinal cord. Am J Pathol (2000) 1.11
Vascular adhesion molecules in acute and chronic liver inflammation. Hepatology (1992) 1.09
Cytogenetic, clinical, and morphologic correlations in 78 cases of fibromatosis: a report from the CHAMP Study Group. CHromosomes And Morphology. Mod Pathol (2000) 1.08
Major histocompatibility class II expression on the small intestinal nervous system in Crohn's disease. Gastroenterology (1992) 1.08
Changing phenotype of gastrointestinal stromal tumours under imatinib mesylate treatment: a potential diagnostic pitfall. Histopathology (2005) 1.07
Light chain deposition disease of the liver associated with AL-type amyloidosis and severe cholestasis. J Hepatol (1991) 1.07
Diffusion-weighted MRI in sporadic Creutzfeldt-Jakob disease. Neurology (1999) 1.06
New sites of human S-100 immunoreactivity detected with monoclonal antibodies. Am J Clin Pathol (1986) 1.06
Clinical impact of molecular and cytogenetic findings in synovial sarcoma. Genes Chromosomes Cancer (2001) 1.06
Hepatitis B surface antigen (HBsAg) in the liver of patients with hepatitis; a comparison with serological detection. J Clin Pathol (1976) 1.05
Vascular endothelial growth factor counteracts the loss of phospho-Akt preceding motor neurone degeneration in amyotrophic lateral sclerosis. Neuropathol Appl Neurobiol (2007) 1.05
Integrins as differential cell lineage markers of primary liver tumors. Am J Pathol (1993) 1.05
Immature sinus histiocytosis. Light- and electron-microscopic features, immunologic phenotype, and relationship with marginal zone lymphocytes. Am J Pathol (1985) 1.05
Clear cell sarcoma of the stomach. Histopathology (2002) 1.05
[Lipoma and atypical lipomatous tumor within the same neoplasia: Evidence for a continuous transition]. Pathologe (2010) 1.04
Distribution of the VLA family of integrins in normal and pathological human liver tissue. Gastroenterology (1991) 1.04
Expression of MHC products by normal and abnormal bile duct epithelium. J Hepatol (1986) 1.04
Cellular angiofibroma: another mesenchymal tumour with 13q14 involvement, suggesting a link with spindle cell lipoma and (extra)-mammary myofibroblastoma. Histopathology (2007) 1.04
Granulomatous gastritis: a morphological and diagnostic approach. Histopathology (1993) 1.03
Various regions within the alpha-helical domain of the COL1A1 gene are fused to the second exon of the PDGFB gene in dermatofibrosarcomas and giant-cell fibroblastomas. Genes Chromosomes Cancer (1998) 1.03
Combined morphologic and karyotypic study of 28 myxoid liposarcomas. Implications for a revised morphologic typing, (a report from the CHAMP Group). Am J Surg Pathol (1996) 1.02
1q gain and CDT2 overexpression underlie an aggressive and highly proliferative form of Ewing sarcoma. Oncogene (2011) 1.02
Molecular cytogenetic mapping of recurrent chromosomal breakpoints in tenosynovial giant cell tumors. Virchows Arch (2002) 1.02
Lesions of 13q may occur independently of deletion of 16q in spindle cell/pleomorphic lipomas. Histopathology (1997) 1.01
Myofibroblastoma of the breast: genetic link with spindle cell lipoma. J Pathol (2000) 1.01
TuBaFrost 3: regulatory and ethical issues on the exchange of residual tissue for research across Europe. Eur J Cancer (2006) 1.01
Expression of the novel extracellular matrix component tenascin in normal and diseased human liver. An immunohistochemical study. J Hepatol (1990) 1.01
The significance of perineural spread in adenoid cystic carcinoma of the major and minor salivary glands. Int J Oral Maxillofac Surg (1988) 1.01
Ketoconazole-associated hepatic injury. A clinicopathological study of 55 cases. J Hepatol (1986) 1.00
Progressive intrahepatic cholestasis (Byler's disease): case report. Gut (1975) 1.00
Hyaline vascular Castleman's disease with HMGIC rearrangement in follicular dendritic cells: molecular evidence of mesenchymal tumorigenesis. Am J Surg Pathol (2002) 1.00
alpha-1-Antitrypsin immunoreactivity in islet cells of adult human pancreas. Cell Tissue Res (1977) 1.00